- Home
- RLAY vs KTOS Comparison
RLAY vs KTOS Comparison
Compare RLAY & KTOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLAY
- KTOS
- Stock Information
- Founded
- RLAY 2015
- KTOS 1994
- Country
- RLAY United States
- KTOS United States
- Employees
- RLAY N/A
- KTOS N/A
- Industry
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- KTOS Military/Government/Technical
- Sector
- RLAY Health Care
- KTOS Industrials
- Exchange
- RLAY Nasdaq
- KTOS Nasdaq
- Market Cap
- RLAY 576.1M
- KTOS 6.2B
- IPO Year
- RLAY 2020
- KTOS 1999
- Fundamental
- Price
- RLAY $3.60
- KTOS $51.53
- Analyst Decision
- RLAY Strong Buy
- KTOS Buy
- Analyst Count
- RLAY 11
- KTOS 11
- Target Price
- RLAY $18.40
- KTOS $44.91
- AVG Volume (30 Days)
- RLAY 1.6M
- KTOS 5.3M
- Earning Date
- RLAY 08-05-2025
- KTOS 08-06-2025
- Dividend Yield
- RLAY N/A
- KTOS N/A
- EPS Growth
- RLAY N/A
- KTOS N/A
- EPS
- RLAY N/A
- KTOS 0.13
- Revenue
- RLAY $7,679,000.00
- KTOS $1,161,700,000.00
- Revenue This Year
- RLAY $17.59
- KTOS $15.46
- Revenue Next Year
- RLAY N/A
- KTOS $15.70
- P/E Ratio
- RLAY N/A
- KTOS $446.51
- Revenue Growth
- RLAY N/A
- KTOS 7.32
- 52 Week Low
- RLAY $1.78
- KTOS $17.91
- 52 Week High
- RLAY $10.72
- KTOS $52.57
- Technical
- Relative Strength Index (RSI)
- RLAY 57.25
- KTOS 73.26
- Support Level
- RLAY $3.50
- KTOS $42.81
- Resistance Level
- RLAY $3.86
- KTOS $46.25
- Average True Range (ATR)
- RLAY 0.18
- KTOS 2.75
- MACD
- RLAY 0.02
- KTOS 0.38
- Stochastic Oscillator
- RLAY 65.79
- KTOS 93.00
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About KTOS Kratos Defense & Security Solutions Inc.
Kratos Defense & Security Solutions Inc develops and fields transformative, affordable technology, platforms, and systems. The company has two segments; The Kratos Government Solutions (KGS) segment is comprised of an aggregation of KGS operating segments, including its microwave electronic products, space, training, and cybersecurity, C5ISR/modular systems, turbine technologies, and defense and rocket support services operating segments and The Unmanned Systems segment consists of unmanned aerial, unmanned ground, unmanned seaborne and related command, control, and communications system businesses. The company derives a majority of its revenue from the Kratos Government Solutions segment.